Regeneron (REGN), Sanofi (SNY) Report Dupilumab Receives FDA Breakthrough Designation as AD Treatment
Tweet Send to a Friend
Regeneron (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
